0001447362-21-000040.txt : 20210310
0001447362-21-000040.hdr.sgml : 20210310
20210310160818
ACCESSION NUMBER: 0001447362-21-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210310
DATE AS OF CHANGE: 20210310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRADBURY DANIEL
CENTRAL INDEX KEY: 0001236397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 21729756
MAIL ADDRESS:
STREET 1: BIOBRIT, LLC
STREET 2: 2223 AVENIDA DE LA PLAYA, SUITE 108
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770701774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
4
1
wf-form4_161541047963828.xml
FORM 4
X0306
4
2021-03-08
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001236397
BRADBURY DANIEL
C/O CASTLE BIOSCIENCES, INC.
820 S. FRIENDSWOOD DRIVE, SUITE 201
FRIENDSWOOD
TX
77546
1
0
0
0
Common Stock
2021-03-08
4
S
0
1700
65.894
D
349293
I
By LLC
Common Stock
2021-03-08
4
S
0
2795
67.10
D
346498
I
By LLC
Common Stock
2021-03-08
4
S
0
1805
68.041
D
344693
I
By LLC
Common Stock
2021-03-08
4
S
0
1200
68.961
D
343493
I
By LLC
Common Stock
2021-03-09
4
S
0
2675
61.802
D
340818
I
By LLC
Common Stock
2021-03-09
4
S
0
1914
62860
D
338904
I
By LLC
Common Stock
2021-03-09
4
S
0
387
64.044
D
338517
I
By LLC
Common Stock
2021-03-09
4
S
0
995
65.264
D
337522
I
By LLC
Common Stock
2021-03-09
4
S
0
383
66.022
D
337139
I
By LLC
Common Stock
2021-03-09
4
S
0
946
67.284
D
336193
I
By LLC
Common Stock
2021-03-09
4
S
0
200
68.81
D
335993
I
By LLC
Common Stock
157781
I
By Daniel Bradbury Irrecovable Descendant's Trust
Common Stock
157804
I
By Annette Bradbury Irrecovable Descendant's Trust
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020.
This transaction was executed in multiple trades at prices ranging from $65.480 to $66.460, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
This transaction was executed in multiple trades at prices ranging from $66.495 to $67.445, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $67.620 to $68.450, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $68.730 to $69.380, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $61.270 to $62.260, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $62.420 to $63.300, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $63.570 to $64.550, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $64.710 to $65.690, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $65.720 to $66.680, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $66.900 to $67.750, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
/s/ Greg Acosta, Attorney-in-fact
2021-03-10